LHX vs VRCA · P/E 34, rev $5.88B vs rev $10.9M
L3Harris Technologies Inc (LHX) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the LHX and VRCA stock pages for the full models.
Not investment advice.